CITED CLIPS

MDMA Therapy Breakthrough

A groundbreaking study reveals that MDMA-assisted therapy boasts an impressive 88% success rate for treating PTSD, significantly outperforming traditional therapy with placebo at 60%. Remarkably, 67% of participants in the MDMA group no longer met the criteria for PTSD by the treatment's end, highlighting the potential for MDMA to transition from a Schedule I drug to a clinically applicable treatment. This shift could reshape the landscape of psychiatric care as early as 2024.